Clear Street’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$110 610
2024
Q4
$110 Buy
+100
New +$119 ﹤0.01% 540
2024
Q2
Sell
-41,169
Closed -$41.2K 829
2024
Q1
$41.2K Sell
41,169
-9,246
-18% -$9.23K ﹤0.01% 214
2023
Q4
$60K Buy
+50,415
New +$22.3K ﹤0.01% 160
2023
Q3
Sell
-102
Closed -$4 1293
2023
Q2
$4 Buy
102
+2
+2% ﹤0.01% 1301
2023
Q1
$6 Sell
100
-242,241
-100% -$21.4K ﹤0.01% 1177
2022
Q4
$18K Hold
242,341
﹤0.01% 399
2022
Q3
$15K Hold
242,341
﹤0.01% 527
2022
Q2
$20K Buy
+242,341
New +$46.3K ﹤0.01% 406

Other funds holding TLSIW

Clear Street's TLSIW Position: Q1 2025 in Review

Clear Street sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2025, closing a stake of 100 shares — an estimated $110 sold.

Clear Street first reported a position in TLSIW in Q2 2022 and held it in 8 quarters. The position peaked at $60K in Q4 2023. 6 funds tracked by Wall St. Rank hold TLSIW as of Q1 2025.

  • Clear Street reported no remaining TriSalus Life Sciences Warrant position as of Q1 2025 after selling out during the quarter.
  • Clear Street sold 100 TriSalus Life Sciences Warrant shares in Q1 2025, an estimated $110.
  • Clear Street first reported a position in TriSalus Life Sciences Warrant in Q2 2022 and held it in 8 quarters.
  • Clear Street's TriSalus Life Sciences Warrant position peaked at $60K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2025.

Based on Clear Street's 13F filing for Q1 2025, filed 15 May 2025.